CD44 and breast carcinoma: Inhibiting autophagy in triple-negative breast CSCs inhibited the STAT3/JAK2 pathway-mediated production of IL-6, a cytokine critical for CSC survival and required to produce the CD44+/CD24low phenotype in breast cancer cell lines [148].